The association between SGLT2 inhibitors and rheumatoid arthritis risk in type 2 diabetes: findings from large-scale emulated target trials
IntroductionGlobally, the prevalence of rheumatoid arthritis (RA) is on the rise. Certain antidiabetic medications have been reported to lower the risk of RA. In this study, we conducted multicenter emulated target trials to compare the risk of RA deve…